GGrantIndex
Sort

15,842 grants matching pancreatic cancer

Mechanism-Based Use of Chk1 Inhibitors in Pancreas Cancer

$412,452
Jonathan Maybaum · University Of Michigan At Ann Arbor · R01 · FY2013 · CA

South-Eastern Center for Imaging Animal Models of Cancer

$412,421
John C Gore · Vanderbilt University · U24 · FY2008 · CA

Targeting Focal Adhesion Kinase to Improve RT-inducted Tumor Immunity

$412,324
David G Denardo · Washington University · R01 · FY2024 · CA

A SYNTHETIC BIOMARKER TO UNIVERSALLY ASSESS THE RELATIVE CONTRIBUTION OF HEATHY AND CANCEROUS TISSUE TO CIRCULATING EV POOL

$412,277
Emanuele Cocucci · Ohio State University · R01 · FY2024 · CA

A Clinical Center to Study Immunological and Hormonal Biomarkers for the Diagnosis, Prediction and Treatment of Chronic Pancreatitis and its associated development to Diabetes and Pancreas Cancer

$412,196
Walter Gwang-Up Park · Stanford University · U01 · FY2016 · DK

Molecular mechanism of regulation and activation of membrane proteins in native membrane milieu

$412,000
Moitrayee Bhattacharyya · Yale University · R35 · FY2024 · GM

Molecular mechanism of regulation and activation of membrane proteins in native membrane milieu

$412,000
Moitrayee Bhattacharyya · Yale University · R35 · FY2025 · GM

Role of MFG-E8 in Tumor Biology ans Immunophysiology

$411,997
Mark Udey · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA

Real-time monitoring of circulating pancreatic tumor cells and clusters

$411,981
Erica Carpenter · University Of Pennsylvania · R01 · FY2019 · CA

Advanced Development of the MasSpec Pen for Cancer Diagnosis and Surgical Margin Evaluation

$411,941
Livia Schiavinato Eberlin · University Of Texas At Austin · R33 · FY2019 · CA

Helicobacter Pylori and Gastrointestinal Biology

$411,935
Richard M Peek · Vanderbilt University Medical Center · R01 · FY2021 · DK

Neutralizing Stromal NetrinG1 to Intercept Pancreatic Cancer

$411,831
Edna Cukierman · Research Inst Of Fox Chase Can Ctr · U54 · FY2023 · CA

Investigation of novel signaling protein in 3D and in vivo PDAC models using second generation Ref-1 inhibitors

$411,790
Melissa L Fishel · Indiana University Indianapolis · R01 · FY2024 · CA

Study Of Factors That Induce Differentiation Of Pancreatic Precursor Cells

$411,625
Marvin Gershengorn · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2011 · DK

Novel Strategies for Precision T-cell Therapies

$411,577
Steven C. Almo · Albert Einstein College Of Medicine, Inc · R01 · FY2018 · CA

Project 3: Chronic interferon and bile acid signaling as drivers of immunosuppression in age-related liver cancer

$411,554
Susan M Kaech · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2023 · AG

Project 3: Transcriptomic subtypes, response predictions, and therapy selection

$411,480
Jen Jen Yeh · Univ Of North Carolina Chapel Hill · P50 · FY2023 · CA

Project 1: Targeting Tumor Phospholipase PLA2G10 for Cancer Immunotherapy

$411,417
Kurt A Schalper · Yale University · P50 · FY2025 · CA

Tumor Glycomics Laboratory for Discovery of Pancreatic Cancer Markers

$411,357
James Michael Pierce · University Of Georgia · U01 · FY2008 · CA

Tumor Glycomics Laboratory for Discovery of Pancreatic Cancer Markers

$411,353
James Michael Pierce · University Of Georgia · U01 · FY2009 · CA

Targeted therapy of peritoneal carcinomatosis using theranostic nanoparticles

$411,268
Lily Yang · Emory University · R01 · FY2020 · CA

Targeted therapy of peritoneal carcinomatosis using theranostic nanoparticles

$411,268
Lily Yang · Emory University · R01 · FY2018 · CA

Targeted therapy of peritoneal carcinomatosis using theranostic nanoparticles

$411,268
Lily Yang · Emory University · R01 · FY2017 · CA

Leveraging deep learning for markerless motion management in radiation therapy

$411,262
Lei Xing · Stanford University · R01 · FY2024 · CA

Targeting cancer cachexia drivers using antibody-based approaches

$411,209
Azeddine Atfi · Virginia Commonwealth University · R01 · FY2024 · CA